GGrantIndex
Sort

21,281 grants matching influenza

Biodefense/Emerging Infection Vaccine Studies

$4,251,944
Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Design and evaluation of pan-CoV vaccines

$4,242,156
Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2021 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$4,238,840
Walter A. Orens · Emory University · N01 · FY2016 · AI

Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity

$4,237,040
Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2024 · AI

Center for Accelerating Excellence in Translational Science (AXIS)

$4,236,648
Jose A Torres-Ruiz · Charles R. Drew University Of Med & Sci · U54 · FY2025 · MD

Biodefense and Emerging Infectious Disease Vaccine Studies

$4,228,945
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Influenza and Emerging Infectious Diseases

$4,224,059
Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$4,221,049
John Jay Treanor · University Of Rochester · N01 · FY2014 · AI

Project 2: PanbetaCoV protein vaccine design

$4,217,384
Kevin Wiehe · Duke University · P01 · FY2021 · AI

Small molecule inhibitors of enveloped virus entry

$4,204,548
Sean P. J. Whelan · Harvard Medical School · U19 · FY2015 · AI

DEVELOPMENT OF A NOVEL CELL-BASED, LIVE INFLUENZA VACCINE WITH UNIVERSAL ATTRIBUTES

$4,198,890
Flugen Inc · · FY2019 · Department of the Army

DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES

$4,191,765
Wilson Russell · Autoimmune Technologies, Llc · N01 · FY2016 · AI

NIAID Centers of Excellence for Influenza Research and Response

$4,189,961
Scott Hensley · University Of Pennsylvania · N01 · FY2025 · AI

Resources, Workforce Development, and Animal Models for the Rutgers RBL

$4,189,403
David Alland · Rutgers Biomedical And Health Sciences · UC7 · FY2024 · AI

ARRA: H1N1 Influenza Disease Modeling and Transmission

$4,154,469
Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross

$4,148,261
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI

Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross

$4,144,540
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$4,138,539
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2017 · AI

GH16-006: Conducting Public Health Research in Kenya

$4,119,310
Christopher D Bayer · Hjf Medical Research International, Inc. · U01 · FY2017 · GH

Clinical Studies of Vaccines for Pandemic Influenza

$4,115,191
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Emerging Infections Program

$4,110,577
Guthrie S Birkhead · Nysdoh/Health Research, Inc. · U01 · FY2011 · CI

Modeling Host Responses to Understand Severe Human Virus Infections

$4,107,674
Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2013 · AI

Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection

$4,104,239
Mark M Davis · Stanford University · U19 · FY2017 · AI

Pandemic Influenza Translational Research and Novel Drug Therapy

$4,071,797
Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core

$4,065,402
Jill Frankenfield · University Of Maryland Baltimore · N01 · FY2025 · AI